- Home
- Services
- usa pennsylvania
- radiotherapies
Show results for
Refine by
Radiotherapies Services In Usa Pennsylvania
6 services found
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Radiopharmaceutical therapies represent an effective way to treat solid cancers by using tumor targeting small molecules, peptides or biologics to deliver a cytotoxic payload that induces DNA damage in tumor cells, while limiting damage to normal and healthy tissue. Streamlined development, evaluation and clinical translation of radiopharmaceuticals requires a partner that has extensive ...
Manufactured by:Galera Therapeutics, Inc. based inMalvern, PENNSYLVANIA (USA)
Radiation Therapy-Induced Oral Mucositis: Oral mucositis (OM) is a common and debilitating toxicity for patients being treated with radiation therapy for head and neck cancers (HNC). OM consists of redness (erythema), swelling, sores (ulcers) and breakdown of the oral mucosa, or lining of the oral cavity. OM causes substantial pain and can interfere with the patient’s ability to eat and/or ...
Manufactured by:Galera Therapeutics, Inc. based inMalvern, PENNSYLVANIA (USA)
We believe that precisely targeting oxygen metabolic pathways has the potential to offer unique and powerful strategies for treating cancer and addressing treatment-related side effects such as oral ...
Manufactured by:Galera Therapeutics, Inc. based inMalvern, PENNSYLVANIA (USA)
Harnessing the Anticancer Power of Hydrogen Peroxide: As cancer cells are more susceptible than normal cells to increased levels of hydrogen peroxide, we believe the conversion of radiation-generated superoxide to hydrogen peroxide by our selective dismutase mimetics can improve outcomes for patients who receive radiation ...
Manufactured by:Galera Therapeutics, Inc. based inMalvern, PENNSYLVANIA (USA)
The cornerstone of our work is the recognition that oxygen metabolic pathways play important roles in human biology and ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Prostate cancer is the most common type of cancer (aside from skin) in American men with 13 out of every 100 being diagnosed with the disease during their lifetime.1,2Prostate-specific membrane antigen (PSMA) is a transmembrane protein that is expressed in high levels in prostate cancer cells. Due to its location on the cell surface, PSMA is a popular target for imaging to identify the presence ...
